Abstract
A novel nanoparticle delivery system has been developed by employing the oppositely charged polymers chitosan (CS) and dextran sulfate (DS), and a simple coacervation process. Under the conditions investigated, the weight ratio of the two polymers is identified as a determining factor controlling particle size, surface charge, entrapment efficiency and release characteristics of the nanoparticles produced. Particles of 223 nm mean diameter were produced under optimal conditions with a zeta potential of approximately −32.6 mV. A maximum of 75 anti-angiogenesis peptide entrapment efficiency was achieved with a CS:DS weight ratio of 0.59:1. The same nanoparticle formulation also showed slow and sustained peptide release over a period of 6 days. In contrast, the formulation containing a lower ratio of CS:DS (0.5:1) was found to have reduced entrapment efficiency and more rapid peptide release characteristics. The results of this study suggest that physicochemical and release characteristics of the CS–DS nanoparticles can be modulated by changing ratios of two ionic polymers. The novel CS–DS nanoparticles prepared by the coacervation process have potential as a carrier for small peptides.
Similar content being viewed by others
References
W. Paul C.P. Sharma (2000) S.T.P. Pharma Sci. 10 5 Occurrence Handle1:CAS:528:DC%2BD3cXit12lurw%3D
K.A. Janes P. Calvo M.J. Alonso (2001) Adv. Drug Deliv. Rev. 47 83 Occurrence Handle10.1016/S0169-409X(00)00123-X Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsrY%3D Occurrence Handle11251247
Y. Xu Y. Du (2003) Int. J. Pharm. 250 215 Occurrence Handle10.1016/S0378-5173(02)00548-3 Occurrence Handle1:CAS:528:DC%2BD38Xpt12qsb8%3D Occurrence Handle12480287
J.L. Chew C.B. Wolfowicz H.-Q. Mao K.W. Leong K.Y. Chua (2003) Vaccine 21 2720 Occurrence Handle10.1016/S0264-410X(03)00228-7 Occurrence Handle1:CAS:528:DC%2BD3sXksVyrurY%3D Occurrence Handle12798609
H.-Q. Mao K. Roy V.L. Troung-Le K.A. Janes K.Y. Lin Y. Wang J.T. August K.W. Leong (2001) J. Cont. Rel. 70 399 Occurrence Handle1:CAS:528:DC%2BD3MXhtV2murs%3D
H. Takeuchi H. Yamamoto Y. Kawashima (2001) Adv. Drug Deliv. Rev. 47 39 Occurrence Handle10.1016/S0169-409X(00)00120-4 Occurrence Handle1:CAS:528:DC%2BD3MXhvVajsrs%3D Occurrence Handle11251244
Y. Chen R.K. McCulloch B. N. Gray (1994) J. Cont. Rel. 31 49 Occurrence Handle1:CAS:528:DyaK2cXlsVWnsrc%3D
K.A. Janes M.P. Fresneau A. Marazuela A. Fabra M.J. Alonso (2001) J. Cont. Rel. 73 255 Occurrence Handle1:CAS:528:DC%2BD3MXksVSqur0%3D
W. Tiyaboonchai J. Woiszwillo C.R. Middaugh (2003) Eur. J. Pharm. Sci. 19 191 Occurrence Handle1:CAS:528:DC%2BD3sXls1Onu7Y%3D Occurrence Handle12885383
W. Tiyaboonchai J. Woiszwillo R.C. Sims C.R. Middaugh (2003) Int. J. Pharm. 255 139 Occurrence Handle10.1016/S0378-5173(03)00055-3 Occurrence Handle1:CAS:528:DC%2BD3sXisVGks7w%3D Occurrence Handle12672610
M. Tobio R. Gref A. Sanchez R. Langer M.J. Alonso (1998) Pharm. Res. 15 270 Occurrence Handle1:CAS:528:DyaK1cXhsFCntL0%3D Occurrence Handle9523314
Q. Zhang Z. Shen T. Nagai (2001) Int. J. Pharm. 218 75 Occurrence Handle10.1016/S0378-5173(01)00614-7 Occurrence Handle1:CAS:528:DC%2BD3MXjtV2ltr8%3D Occurrence Handle11337151
D.Q. Guerrero E. Allemann H. Fessi E. Doelker (1988) Drug Dev. Ind. Pharm. 24 1113
D.G. Bae Y.S. Gho W.H. Yoon C.B. Chae (2000) J. Biol. Chem. 275 13588 Occurrence Handle1:CAS:528:DC%2BD3cXjtFyktLg%3D Occurrence Handle10788475
P. Calvo C. Remunan-Lopez J.L. Vila-Jato M.J. Alonso (1997) Pharm. Res. 14 1431 Occurrence Handle10.1023/A:1012128907225 Occurrence Handle1:CAS:528:DyaK2sXntFeht7g%3D Occurrence Handle9358557
T. Bantan-Polak M. Kassai K.B. Grant (2001) Anal. Biochem. 297 128 Occurrence Handle10.1006/abio.2001.5338 Occurrence Handle1:CAS:528:DC%2BD3MXnslWgs70%3D Occurrence Handle11673879
P. Calvo C. Remunan-Lopez J.L. Vila-Jato M.J. Alonso (1997) J. Appl. Poly. Sci. 63 125 Occurrence Handle10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 Occurrence Handle1:CAS:528:DyaK2sXhvV2rug%3D%3D
R. Fernandez-Urrusuno P. Calvo C. Remunan-Lopez J.L. Vila-Jato M.J. Alonso (1999) Pharm. Res. 6 1576
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, Y., Mohanraj, V.J. & Parkin, J.E. Chitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide. Int J Pept Res Ther 10, 621–629 (2003). https://doi.org/10.1007/s10989-004-2433-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10989-004-2433-4